Determination of Glycemic Index (GI) of Ten Food Products

August 1, 2014 updated by: Danone Asia Pacific Holdings Pte, Ltd.
This study is initiated to investigate the glycemic index value of ten food products.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore
        • Temasek Polytechnic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy non-pregnant females (at least 6 weeks postpartum, non-lactating)
  • Age between 21 to 60 years

Exclusion Criteria:

  • Suffering from any chronic diseases.
  • Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
  • History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
  • Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
  • Known food allergy or intolerance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Food products
Ten food products will be given to all subjects
Dietary supplement: Food products

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic index values of all ten products
Time Frame: 120 minutes post adminstration
Glycemic index values at 120 minutes post adminstration.
120 minutes post adminstration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Danone Asia Pacific Holdings Pte, Ltd.

Investigators

  • Principal Investigator: Kalpana Bhaskaran, Dr, Temasek Polytechnic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

April 1, 2012

Study Completion (Actual)

April 1, 2012

Study Registration Dates

First Submitted

August 30, 2012

First Submitted That Met QC Criteria

September 5, 2012

First Posted (Estimate)

September 6, 2012

Study Record Updates

Last Update Posted (Estimate)

August 4, 2014

Last Update Submitted That Met QC Criteria

August 1, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • GIS.2012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycemic Index

Clinical Trials on Food products

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe